Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11413278
Compounds and methods for promoting stress resistance
granted -
US 11414423
Substituted 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles for treating brain disorders
granted -
US 11413296
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
granted -
US 11407990
Fusion proteins and methods for site-directed genome editing
granted -
US 11407998
Twist signaling inhibitor compositions and methods of using the same
granted -
US 11407649
Cerium (III) carbonate formulations
granted -
US 11406721
Compositions and methods for imaging cell populations
granted -
US 11406597
Fusogenic liposome-coated porous silicon nanoparticles
granted -
US 11400098
Method of treating microbial infections
granted -
US 11400104
Skeletal removal of bisphosphonates
granted -
US 11400284
Method of transcutaneous electrical spinal cord stimulation for facilitation of locomotion
granted -
US 11401532
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 11401332
Proteolytically cleavable chimeric polypeptides and methods of use thereof
granted -
US 11400116
Systems and methods for targeting cancer cells
granted -
US 11389396
Tumescent antibiotic injection for treatment of chronic skin and soft tissue infections
granted -
US 11390667
Compositions and methods for the treatment of neuromyelitis optica
granted -
US 11390646
Structure-based peptide inhibitors of α-synuclein aggregation
granted -
US 11382890
Prevention of rosacea inflammation
granted -
US 11384350
Cytotoxic molecules responsive to intracellular ligands for selective T cell mediated killing
granted -
US 11382955
Long-acting VEGF inhibitors for intraocular neovascularization
granted -
US 11382885
Compositions for treating fungal and bacterial biofilms and methods of using the same
granted -
US 11377646
Modified cells comprising CRISPR systems
granted -
US 11376346
Extracellular matrix for treating pelvic floor disorders and skeletal muscle degeneration
granted -
US 11377451
Compositions and methods for treating cancer
granted